Oplon Pure Science Ltd.

www.oplon.com

Formerly Sure, BioActivity

High-Tech Company

Suspended Operations Q4/2015

TECH VERTICALS

Biotechnology, Industrial, Life Sciences, MedTech

General Data

Sector	Biomed
Company Stage:	Initial Revenues
Established	2006
Number of Employees	3
Reg. Number:	abCDe

DESCRIPTION

Oplon is a materials science company that develops protective products, coatings and processes, based on a novel polymer compound. Oplon's coatings prevent the colonization of microbes by creating a protective physical shield on surfaces.

TECHNOLOGY

Oplon's technology is engaged in research and development related to controlling the population of microorganisms, methods of killing microorganisms, antimicrobial materials, and processes of applying antimicrobial materials to a variety of packaging solutions.

Oplon has developed a range of effective surface protection, as well as antimicrobial compounds that are used as coatings. These coatings challenge the negative effects of contamination and provide safe and cost effective alternatives to the traditional approaches.

Oplon’s antimicrobial coatings are an advanced composition of polyelectrolytes contained within a polymer matrix. On contact with liquids, a surface electric field is created, which disrupts cell membranes safely, effectively and inexpensively . Based on this physical phenomenon, Oplon's coatings act as an electric shield that kills yeast, mold, bacteria and certain viruses - disrupting and destroying them upon contact.

Oplon’s physics-based technology protects against a wide spectrum of bacteria and fungi, including antibiotic resistant and heat resistant pathogens. Oplon's materials are non-toxic, environmentally friendly, and do not leach or release chemicals.

	TARGET MARKETS
	Food Companies, Textile Factories, Manufacturers of medical equipment, Manufacturers of water treatment equipment.

	BUSINESS MODEL
	B2B

CONTACT INFO

Expand / Collapse All

Main Address: Ness Ziona, Israel

Address	18 Einstein St.
City	Ness Ziona
Country	Israel
Zip	7403622

Contact Person	abC Defghij
Contact E-Mail	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

	MANAGEMENT

Key Executive

Name	Title	Previous Position
Mr. Ronen Melnik	Interim CEO	McKinsey Israel (Partner)
Mr. Marc Tobin	General Councel	2BVentures (Managing Director)
Dr. Shmuel Bukshpan	Chief Scientist & Co-Founder
Dr. Uriel Halavee	Co-Founder
Mr. Gleb Zilberstein	Co-Founder

	BOARD

Board

Member	Title	Affiliation
abC Defghij	Chairman	Managing Partner & Co-Founder, Wanaka
abC Defghij	Board Member	Co-Founder, Oplon
abC Defghij	Board Member	Director General, Tel Aviv Sourasky Medical Center
abC Defghij	Board Member	Chief Scientist & Co-Founder, Oplon
abC Defghij	Board Member	Chairman of the Board , C. Mer Industries
abC Defghij	Board Member	Co-Founder & Former Chief Scientist, Ethrog Biotechnology
abC Defghij	Chairman of Scientific Advisory Board	Member, US National Academy of Sciences
abC Defghij	Scientific Advisor	Professore & Chair of the Department of Structural Biology, Stanford University
abC Defghij	Scientific Advisor	Benno Gitter & Ilana Ben Ami Chair of Biotechnology, Technion's Faculty of Chemistry
abC Defghij	Scientific Advisor	Wolfson Family Professor of Biochemistry, the Hebrew University

	FINANCIAL ROUNDS

Total Capital Raised
abCDe

Financial Rounds

Numbers of Investors

Expand / Collapse All

Round

Date

Stage

Amount

Valuation

Second Round

Dec. 01, 2009

R&D

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Holding Company	abCDe
abC Defghij	Private Investor	abCDe

First Round

Apr. 01, 2008

R&D

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Venture Capital Fund	abCDe	Led the round
abC Defghij	Holding Company	abCDe
abC Defghij	Private Investor	abCDe

Seed

Mar. 01, 2007

Seed

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Holding Company	abCDe
abC Defghij	Private Investor	abCDe

	R&D Grants

Expand / Collapse All

Round

Date

Stage

Amount

Remarks

R&D Grant

Jul. 02, 2012

abCDe

Oplon Pure Science and U.S. Company will develop an antimicrobial solution for PET bottles.

* New investor

Investor	Type	Amount	Remarks
abC Defghij*	Bi-National Fund	abCDe

Last Updated:	abCDe
IVC Number:	abCDe